
|Articles|January 6, 2023
Thinking Big for Small and Mid-Sized Biotechs: How Applying Modeling Technologies Can Improve Drug Development
Author(s)Allucent
Allucent’s Katy Moore, Pharm. D., R.Ph. President, Clinical Pharmacology Modeling and Simulation, offers insightful commentary for small and mid-sized biotechs developing scientific breakthroughs. Learn from Katy’s expertise how applying modeling and simulation can improve drug development and help bring new therapies to light.
Trending on Applied Clinical Trials Online
1
HHS Launches Operation TrialBlazer to Restore US Leadership in Clinical Research
2
ACT Brief: ICON-Microsoft AI Partnership, DCT Site Burden, and AI-Enabled Neuroimmune Discovery
3
Two Decades of Rising Protocol Complexity: A Longitudinal Analysis of Clinical Trial Design Evolution, 2004–2025
4
ICON Selects Microsoft as Preferred Technology Partner to Scale Agentic AI Platform Across Clinical Trial Lifecycle
5